In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia
AUTOR(ES)
Abbey, Craig K.
FONTE
National Academy of Sciences
RESUMO
Imaging mouse models of human cancer promises more effective analysis of tumor progression and reduction of the number of animals needed for statistical power in preclinical therapeutic intervention trials. This study utilizes positron emission tomography imaging of 2-[18F]-fluoro-deoxy-d-glucose to monitor longitudinal development of mammary intraepithelial neoplasia outgrowths in immunocompetent FVB/NJ mice. The mammary intraepithelial neoplasia outgrowth tissues mimic the progression of breast cancer from premalignant ductal carcinoma in situ to invasive carcinoma. Progression of disease is clearly evident in the positron emission tomography images, and tracer uptake correlates with histological evaluation. Furthermore, quantitative markers of disease extracted from the images can be used to track proliferation and progression in vivo over multiple time points.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=509219Documentos Relacionados
- Positron-emission tomography imaging of long-term shape recognition challenges
- Future of positron-emission tomography in oncology.
- Quantitative imaging of the T cell antitumor response by positron-emission tomography
- Cognitive processes and cerebral cortical fundi: findings from positron-emission tomography studies.
- Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography
